Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000643822 | SCV000765509 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-10-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002360589 | SCV002664816 | uncertain significance | Cardiovascular phenotype | 2019-12-12 | criteria provided, single submitter | clinical testing | The p.R21904W variant (also known as c.65710C>T), located in coding exon 166 of the TTN gene, results from a C to T substitution at nucleotide position 65710. The arginine at codon 21904 is replaced by tryptophan, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV004692016 | SCV005188104 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, |
RCV005405235 | SCV006068906 | likely benign | not specified | 2025-04-09 | criteria provided, single submitter | clinical testing | |
Genome |
RCV004545797 | SCV004037515 | not provided | TTN-related disorder | no assertion provided | phenotyping only | Variant classified as Uncertain significance and reported on 08-21-2017 by Invitae. GenomeConnect-Invitae Patient Insights Network assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. Registry team members make no attempt to reinterpret the clinical significance of the variant. Phenotypic details are available under supporting information. |